Drug
Atg 037
Atg 037: highest development phase Phase 1, developed by Antengene Therapeutics Limited. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Antengene Therapeutics Limited
Trials
| Drug | Phase | Indication |
|---|---|---|
| ATG-037 NCT05205109 | Phase 1 | Locally Advanced or Metastatic Solid Tumors |
Latest
No recent events.
Follow Atg 037 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.